nav open
¸Þ´º
nav open
ȸ»ç¼Ò°³
Àλ縻(±¹¹®)
Àλ縻(About Us)
¿À½Ã´Â ±æ
»ç¾÷¼Ò°³
»ç¾÷¼Ò°³1
»ç¾÷¼Ò°³2
»ç¾÷ºÐ¾ß
»ç¾÷ºÐ¾ß1
»ç¾÷ºÐ¾ß2
»ç¾÷ºÐ¾ß3
¿Â¶óÀι®ÀÇ
¿Â¶óÀι®ÀÇ(Contact)
Ä¿¹Â´ÏƼ
ÀÚ·á½Ç
nav open
ȸ»ç¼Ò°³
Àλ縻(±¹¹®)
Àλ縻(About Us)
¿À½Ã´Â ±æ
»ç¾÷¼Ò°³
»ç¾÷¼Ò°³1
»ç¾÷¼Ò°³2
»ç¾÷ºÐ¾ß
»ç¾÷ºÐ¾ß1
»ç¾÷ºÐ¾ß2
»ç¾÷ºÐ¾ß3
¿Â¶óÀι®ÀÇ
¿Â¶óÀι®ÀÇ(Contact)
Ä¿¹Â´ÏƼ
ÀÚ·á½Ç
Ä¿¹Â´ÏƼ
¾¾¾ÆÀ̹ÙÀÌ¿À´Â ¹ÏÀ½°ú ½Å·Ú¸¦ ¹ÙÅÁÀ¸·Î
±Í»çÀÇ ±¹³», ÇØ¿ÜÁøÃâÀÇ ÆÄÆ®³Ê°¡ µÇ°Ú½À´Ï´Ù.
Ä¿¹Â´ÏƼ
ÀÚ·á½Ç
Ȩ
Ä¿¹Â´ÏƼ
ÀÚ·á½Ç
ÀÚ·á½Ç
¹øÈ£
Á¦¸ñ
ÀÛ¼ºÀÚ
ÀÛ¼ºÀÏÀÚ
Á¶È¸¼ö
°øÁö
Licence in, out , sales service
°ü¸®ÀÚ
2024-07-09
19
°øÁö
FDA ÄÁ¼³ÆÃ, ¹Ì±¹ ÁøÃâ ½ÃÀåÁ¶»ç, Áö¿ø µå¸³´Ï´Ù.
°ü¸®ÀÚ
2023-03-27
96
°øÁö
EU Regulatory MDD ¿¡¼ MDR, IVDR Àüȯ¿¡ µû¸¥ Clinical trialÀ» Æ÷ÇÔÇÑ Áö¿ø¹× Áغñ..
°ü¸®ÀÚ
2023-03-27
74
10
ADC CDMO Service(US FDA,EU EMA, PDMA, NMDA)
°ü¸®ÀÚ
2024-07-02
26
9
Medical related area, Refer to reference (Notice)
°ü¸®ÀÚ
2024-03-14
72
8
diagnostics test
°ü¸®ÀÚ
2023-04-02
92
7
ÇØ¿ÜÀÓ»ó, µî·Ï °í·Á»çÇ×¹× ÁøÇà¹æÇâ (Clinical trial, registration capability For ..
°ü¸®ÀÚ
2023-03-13
81
6
identification of unknown impurities, QC/batch release, etc
°ü¸®ÀÚ
2022-11-11
82
5
Formulation manufacturer applications
°ü¸®ÀÚ
2022-11-11
72
4
Therapeutic area focused examples
°ü¸®ÀÚ
2022-11-11
67
1
2
³»¿ë
ÀÛ¼ºÀÚ
Á¦¸ñ